skip to Main Content
Facebook
LinkedIn
Services
Services
Reshoring Readiness Assessment
Research
Made in USA Survey
Reshoring Guidebook
About the Guidebook
Guidebook Sample Pages
Reshoring Case Studies
Reshoring White Papers
Manufacturing Infographics
Annual Survey of Manufacturers
Thought Leadership
Speakers for Your Event
Published
Newsletters
Reshoring Blog
Trade Wars and Tariff Watch
Podcasts
Events
Reshoring Events
MFG Day 2022
Videos
Survey of Manufacturers
US Manufacturing Profiles
State Economic Profiles
Made in USA: Made In Your State
MFG Day
Biden on Manufacturing
Made in America
Made in America Proclamation
Manufacturing
CHIPS Act
Infrastructure Act
Supply Chains
100 Day Report on Supply Chain
Internships
Interns
University Affiliations
About Us
Our Mission
FAQs
People
Sponsors & Affiliates
Press Releases
Contact Us
Cart
0
Cart
Open Mobile Menu
Cart
Supply chain disruption brings discussion of onshoring pharmaceutical ingredients
May 19, 2020
Daisie Hobson
0 Comments
Share This
Tweet
Share
Share
Email
Leave a Reply
Cancel reply
You must be
logged in
to post a comment.
previous post:
Reshoring gets new attention during COVID-19
next post:
Will Covid-19 Have a Lasting Impact on Globalization
Back To Top
×
